These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3900946

  • 21. Emergence of resistance to multiple beta-lactams in Enterobacter cloacae during treatment for neonatal meningitis with cefotaxime.
    Heusser MF, Patterson JE, Kuritza AP, Edberg SC, Baltimore RS.
    Pediatr Infect Dis J; 1990 Jul; 9(7):509-12. PubMed ID: 2371083
    [No Abstract] [Full Text] [Related]

  • 22. Unusual presentation of primary klebsiella meningitis: successful treatment with cefotaxime.
    Sandyk R, Brennan MJ.
    Postgrad Med J; 1983 Apr; 59(690):256-7. PubMed ID: 6306628
    [Abstract] [Full Text] [Related]

  • 23. Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis.
    Scheld WM, Fink FN, Fletcher DD, Sande MA.
    Antimicrob Agents Chemother; 1979 Sep; 16(3):271-6. PubMed ID: 228591
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of purulent meningitis in the child using Cefotaxime].
    Borderon JC, Despert F, Santini JJ, Laugier J.
    Pediatrie; 1985 Jun; 40(4):291-9. PubMed ID: 3909093
    [Abstract] [Full Text] [Related]

  • 25. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
    Borderon JC, Despert F, Santini JJ, Laugier J, Grenier B, Boulard P.
    Nouv Presse Med; 1981 Feb 26; 10(8):634-8. PubMed ID: 6259609
    [Abstract] [Full Text] [Related]

  • 26. Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.
    Landesman SH, Corrado ML, Shah PM, Armengaud M, Barza M, Cherubin CE.
    Am J Med; 1981 Oct 26; 71(4):693-703. PubMed ID: 6269429
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits.
    Täuber MG, Shibl AM, Hackbarth CJ, Larrick JW, Sande MA.
    J Infect Dis; 1987 Sep 26; 156(3):456-62. PubMed ID: 3302052
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS, Manocchio M, Bayer AS.
    Chemotherapy; 1984 Sep 26; 30(4):262-9. PubMed ID: 6086247
    [Abstract] [Full Text] [Related]

  • 38. Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia spp.
    Eng RH, Cherubin CE, Pechere JC, Beam TR.
    J Antimicrob Chemother; 1987 Dec 26; 20(6):903-11. PubMed ID: 3501999
    [Abstract] [Full Text] [Related]

  • 39. Hospital-acquired neonatal bacterial meningitis: the impacts of cefotaxime usage on mortality and of amikacin usage on incidence.
    Coovadia YM, Mayosi B, Adhikari M, Solwa Z, van den Ende J.
    Ann Trop Paediatr; 1989 Dec 26; 9(4):233-9. PubMed ID: 2482005
    [Abstract] [Full Text] [Related]

  • 40. Update on the use of cefotaxime for pediatric meningitis in Portugal.
    Lecour H, Miranda AM, Nogueira JA, Abreu C.
    Diagn Microbiol Infect Dis; 1995 Dec 26; 22(1-2):125-7. PubMed ID: 7587025
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.